Search results for "obstetric"

showing 10 items of 2144 documents

EP03.06: Assisted reproductive technology and the risk of preterm birth

2018

medicine.medical_specialtyAssisted reproductive technologyReproductive MedicineRadiological and Ultrasound Technologybusiness.industryObstetricsmedicine.medical_treatmentObstetrics and GynecologyMedicineRadiology Nuclear Medicine and imagingGeneral MedicinebusinessUltrasound in Obstetrics & Gynecology
researchProduct

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

2021

Geburtshilfe und Frauenheilkunde 81(10), 1112-1120 (2021). doi:10.1055/a-1499-8431

medicine.medical_specialtyAxillary lymph nodesBreast surgerymedicine.medical_treatmentMammakarzinomBreast cancerbreast cancerMaternity and MidwiferyAdjuvant therapymedicineddc:610GebFra ScienceStage (cooking)Sentinel-Lymphknoten-Entfernungtargeted axillary dissectionsentinel LNEneoadjuvante Chemotherapiebusiness.industryObstetrics and Gynecologymedicine.diseaseRadiation therapyDissectionAxillamedicine.anatomical_structuregezielte axilläre DissektionRadiologybusinessRecommendation/Empfehlungneoadjuvant chemotherapy
researchProduct

A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?

2012

Abstract Background Ovarian cancer (OC) is the sixth most common cancer in women. Currently, carboplatin/paclitaxel ± bevacizumab is the cornerstone of front-line treatment. Conversely, the therapeutic options for recurrent or progressive disease are not well defined. For platinum-sensitive patients the best therapeutic approach is still a re-challenge with a platinum-based regimen. Pegylated liposomal doxorubicin (PLD), is considered one of the most active therapeutic options for recurrent or progressive OC. In this retrospective mono-institutional analysis, we evaluated the impact of PLD on the outcome of OC patients. Patients and methods We performed the retrospective study on a cohort o…

medicine.medical_specialtyBevacizumabUrologySecond line treatmentchemistry.chemical_compoundOvarian cancerPegylated liposomal doxorubicinObstetrics and GynaecologymedicineStage (cooking)Systemic chemotherapyGynecologyPlatinum refractory patientsbusiness.industryResearchObstetrics and GynecologyCancerRetrospective cohort studymedicine.diseaseCarboplatinRegimenenzymes and coenzymes (carbohydrates)OncologychemistryPlatinum refractory patientlipids (amino acids peptides and proteins)Ovarian cancerbusinessProgressive diseasemedicine.drugJournal of ovarian research
researchProduct

Trends in clinical reproductive medicine research : 10 years of growth

2015

[Objective]: To study the most important metrics of publication in the field of reproductive medicine over the decade 2003–2012 to aid in discerning the clinical, social, and epidemiologic implications of this relatively new but rapidly emerging area in medical sciences. [Design]: Bibliometric analysis of most-cited publications from Web of Science databases. [Setting]: Not applicable. [Patient(s)]: None. [Intervention(s)]: None. [Main Outcome Measure(s)]: Most productive and frequently cited investigators, institutions, and countries and specific areas of research, scientific collaborations, and comparison of the growth of reproductive medicine research compared with other areas of medical…

medicine.medical_specialtyBibliometric analysisBiomedical ResearchInternationalityTime FactorsReproductive medicineAlternative medicineBibliometricsObstetrics and gynaecologyCitation analysisObstetrics and Gynaecologymedicinecitation analysisHumansImpact factorCooperative Behaviorimpact factornetwork analysisscientific collaborationImpact factorbusiness.industryObstetrics and GynecologyMaturity (finance)Scientific collaborationCitation analysisReproductive MedicineBibliometricsFamily medicineNetwork analysisJournal Impact Factorbusiness
researchProduct

Dithiothreitol prevents age-associated decrease in oocyte/conceptus viability in vitro.

1998

The present study was designed to ascertain whether the negative effects on reproductive potential of post-ovulatory ageing in vitro of oocytes can be prevented by antioxidant therapy. Mouse metaphase II (MII) oocytes were aged in vitro for 12 h prior to insemination in the presence of varying concentrations of L-ascorbic acid, 6-methoxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox), L-cystine dihydrochloride, ethylenediaminetetraacetic acid (EDTA), beta-mercaptoethanol and DL-dithiothreitol (DTT). In-vitro ageing of oocytes was associated with lower fertilization rate, higher proportion of concepti exhibiting cellular fragmentation at 24 h post-insemination and lower percentage of…

medicine.medical_specialtyBiologyIn Vitro TechniquesDithiothreitolAntioxidantschemistry.chemical_compoundEmbryonic and Fetal DevelopmentMiceHuman fertilizationInternal medicinemedicineAnimalsBlastocystFragmentation (cell biology)Cellular SenescenceRehabilitationSulfhydryl ReagentsObstetrics and GynecologyGlutathioneAscorbic acidOocyteGlutathioneCulture MediaMice Inbred C57BLDithiothreitolOxidative Stressmedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryMice Inbred CBAOocytesFemaleTroloxHuman reproduction (Oxford, England)
researchProduct

Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.

2012

ABSTRACT Objective To describe the effect of the intermittent administration of vaginal progesterone and a low-dose estradiol patch on endometrial stability, as assessed by the rate of amenorrhea and endometrial stimulation. Methods This was an open study in which 64 moderately symptomatic, postmenopausal women were treated in the outpatient clinic of our University Hospital for different intervals up to 1 year. The treatment consisted of a combination of patches delivering 25 µg/day estradiol and intravaginal pills containing 100 mg of micronized progesterone. Patches and pills were administered concomitantly in a twice-a-week protocol. The endometrial response was assessed by endovaginal …

medicine.medical_specialtyBiopsyEndometriumAdministration CutaneousEndometriumBiopsymedicineOutpatient clinicHumansProgesteroneTransdermalUltrasonographyGynecologymedicine.diagnostic_testEstradiolUterine Hemorrhagebusiness.industryEstrogen Replacement TherapyObstetrics and GynecologyGeneral MedicineMiddle AgedUniversity hospitalPostmenopauseAdministration Intravaginalmedicine.anatomical_structurePillAmenorrheaFemaleUterine Hemorrhagemedicine.symptomAtrophybusinessClimacteric : the journal of the International Menopause Society
researchProduct

The influence of oxygen concentration during embryo culture on obstetric and neonatal outcomes: a secondary analysis of a randomized controlled trial.

2020

Abstract STUDY QUESTION Does oxygen concentration during 3-day embryo culture affect obstetric and neonatal outcomes? SUMMARY ANSWER Oxygen concentration during 3-day embryo culture does not seem to affect the obstetric and neonatal outcomes measured. WHAT IS KNOWN ALREADY Atmospheric oxygen appears to be harmful during extended embryo culture. Embryo culture conditions might therefore be a potential risk factor for subsequent fetal development and the health of future children. No data are available concerning the obstetrics and neonatal outcomes after Day 3 transfer of embryos cultured under reduced and atmospheric oxygen tensions. STUDY DESIGN, SIZE, DURATION A secondary analysis of a pr…

medicine.medical_specialtyBirth weight03 medical and health sciencesEgg donation0302 clinical medicinePregnancymedicineHumansChild030304 developmental biologyRetrospective Studies0303 health sciencesPregnancyFetus030219 obstetrics & reproductive medicineObstetricsbusiness.industryRehabilitationInfant NewbornPregnancy OutcomeObstetrics and GynecologyEmbryo culturemedicine.diseaseEmbryo TransferEmbryo transferOxygenReproductive MedicineSpainGestationFemaleLive birthbusinessObstetríciaLive Birth
researchProduct

Maternal sleep duration and neonate birth weight: A population-based cohort study.

2021

Objective Sleep duration is an important health indicator. Our aim was to investigate the association between maternal sleep duration and infant birthweight. Methods The study included 2,536 mother-infant pairs of a Spanish birth cohort (2004-2006, INMA project). The exposures were questionnaire-based measures of sleep duration before and during pregnancy. The primary outcome was infant birthweight score (g) standardized to 40 weeks of gestation. Results In women sleeping less than 7 hours per day before pregnancy, each additional hour of sleep increased birthweight score by 44.7 g (p = 0.049) in the minimally-adjusted model, although findings were not statistically significant after consid…

medicine.medical_specialtyBirth weightMothersAffect (psychology)Cohort Studies03 medical and health sciences0302 clinical medicinePregnancymedicineBirth WeightHumans030212 general & internal medicinePregnancy030219 obstetrics & reproductive medicineObstetricsbusiness.industryConfoundingExcessive sleepInfant NewbornObstetrics and GynecologyGeneral Medicinemedicine.diseaseSleep in non-human animalsDuration (music)Pregnancy Trimester SecondGestationFemalebusinessSleepInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and ObstetricsREFERENCES
researchProduct

Clinical presentation and outcome of 20 fetuses with parvovirus B19 infection complicated by severe anemia and/or fetal hydrops

2014

Aim The aim of this study was to assess the prognosis of parvovirus B19 infection with severely anemic and/or hydropic fetuses according to initial ultrasound and biological criteria. Material and methods Retrospective study of 20 cases of congenital parvovirus B19-proven infection (positive PCR) complicated by fetal anemia and/or hydrops was examined. Anemia was suspected on an elevated peak systolic velocity of the middle cerebral artery and was confirmed by fetal blood sampling. Results Survival rate was 70% (14/20) overall and 76% (13/17) for fetuses with one or more transfusions. When fetal effusion regressed after the transfusion, all 11 fetuses survived, and neonatal condition was fa…

medicine.medical_specialtyBlood transfusionbiologyPleural effusionParvovirusObstetricsAnemiabusiness.industrymedicine.medical_treatmentObstetrics and GynecologyGestational agemedicine.diseasebiology.organism_classificationMirror syndromeSurgeryEffusionmedicinebusinessSurvival rateGenetics (clinical)Prenatal Diagnosis
researchProduct

Impact of estrogens on atherosclerosis and bone in the apolipoprotein E-deficient mouse model.

2014

Objective The common inflammatory pathophysiology has nourished the hypothesis of a relationship between osteoporosis and cardiovascular disease. Estrogens are key agents in the modulation of both processes. We investigated whether induction of atherosclerosis affects bone and whether estrogens modulate both processes. Methods Female apolipoprotein E-deficient mice (a well-established model of atherogenesis) were ovariectomized or falsely operated and fed either standard diet or high-fat diet (HFD). Six animals were included in each of the four groups. To clarify mechanisms, we treated preosteoblastic MC3T3-E1 cells with mouse serum. Results Physiological levels of estrogens in falsely oper…

medicine.medical_specialtyBone densityApolipoprotein BOvariectomyOsteoporosisDiet High-FatBone resorptionMiceApolipoproteins EBone DensityTrabecular PatternInternal medicinemedicineAnimalsHumansBone ResorptionBone mineralbiologybusiness.industryObstetrics and GynecologyEstrogensmedicine.diseaseAtherosclerosisDisease Models AnimalEndocrinologymedicine.anatomical_structureOvariectomized ratbiology.proteinOsteoporosisCortical boneFemalebusinessMenopause (New York, N.Y.)
researchProduct